Cme Group Inc. · NASDAQ:CME

Cme — Q2 2021 Earnings Presentation

7 slides from Cme's earnings presentation, Jul 28, 2021

  1. Slide 1: 2Q21 Summary

    2Q 2021 Earnings Commentary Revenue Adjusted Diluted EPS 2Q21 Summary Adjusted Expense* in millions • CME Group continued to help clients manage their risk and navigate $1,400 CME Group $2.00 uncertainty during the quarter. 2Q21 average daily volume (ADV) of 18.4 (consolidated) million contracts was

  2. Slide 2: 2Q21 Highlights

    2Q 2021 Earnings Commentary - Unaudited 2Q21 Highlights CME Group’s highly diverse product set positions the company well for varying macroeconomic backdrops • 2Q21 ADV increased 5% to 18.4 million contracts • Interest Rates ADV up 25% to 8.6 million contracts Includes 2Q 2021 • Agricultural ADV up

  3. Slide 3: 2Q21 non-U.S. ADV was 5.2 million contracts, up 6% from 2Q20

    2Q 2021 Earnings Commentary - Unaudited 2Q21 non-U.S. ADV was 5.2 million contracts, up 6% from 2Q20 • 2Q21 non-U.S. ADV highlights: • Agricultural ADV up 42% from 2Q20 Non-U.S. ADV by Product Line 2.5 ADV in millions • Interest Rates ADV up 31% from 2Q20 • FX ADV up 15% from 2Q20 2.0 • Metals ADV u

  4. Slide 4: Progressing with formation of leading post-trade services joint venture with IHS Markit

    2Q 2021 Earnings Commentary - Unaudited Progressing with formation of leading post-trade services joint venture with IHS Markit • We continue to make progress with regulatory approvals for the upcoming launch our joint venture with IHS Markit. The combination of these complementary offerings will pr

  5. Slide 5: New Products launched/announced in 2Q21 - continued

    2Q 2021 Earnings Commentary - Unaudited New Products launched/announced in 2Q21 - continued • Interest rate futures based on the Central Bank of Mexico's Overnight TIIE funding rate (F-TIIE) – monthly contracts based on the Mexican F-TIIE rate launched May 24th and receiving industry support. The Me

  6. Slide 6: Financial Results & Guidance

    2Q 2021 Earnings Commentary - Unaudited Financial Results Dividends Paid* $ in millions • 2Q21 revenue was $1.2 billion $2,500 • 2Q21 clearing and transaction fees revenue totaled $930 Regular Quarterly million, including approximately $106 million from cash Dividend markets and optimization service

  7. Slide 7: Use of Non-GAAP Measures; Forward-Looking Statements

    2Q 2021 Earnings Commentary - Unaudited Use of Non-GAAP Measures A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation mate

CME Group — Q2 2021 Earnings Presentation on 6ix